Shares of Ekso Bionics stock traded down $0.20 during trading hours on Thursday, hitting $0.95. The company’s stock had a trading volume of 1,828,372 shares, compared to its average volume of 254,222. The stock has a 50 day moving average price of $1.25. Ekso Bionics has a 12-month low of $0.87 and a 12-month high of $3.30. The firm has a market cap of $89.03 million, a P/E ratio of -2.15 and a beta of 1.44. The company has a current ratio of 1.73, a quick ratio of 1.39 and a debt-to-equity ratio of 0.68.
Ekso Bionics (NASDAQ:EKSO) last announced its quarterly earnings data on Thursday, August 1st. The company reported ($0.04) EPS for the quarter. Ekso Bionics had a negative net margin of 206.32% and a negative return on equity of 501.28%. The business had revenue of $3.26 million during the quarter.
Ekso Bionics Company Profile
Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke.
Featured Article: Why does the United States have a lingering trade deficit?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.